Japan Healthcare Venture Summit
Japanese Early-Stage Technology Companies Opportunities
for Collaboration and Investment
~ Global Business Pitch Session ~
Join a pitching session with early-stage Japanese life sciences SMEs presenting their latest innovations. Discover opportunities for overseas partnerships and investment with some of the most vibrant scientific communities in the world.
14 October 2020 (10 am BST, 11 am CET, 6 pm JST)
Oxentia and the Mitsubishi Research Institute work in partnerships to support Japanese life science SMEs through funding, coaching and business mentoring. Their mission is to ensure the successful commercialisation of products and services for the good of societies around the world.
5 minutes presentation and 3 minutes Q&A sessions
Sleep Apnea Syndrome (SAS) Screening and its new application for preventing Covid-19
Highly purified Mesenchymal Stem Cell “REC” targeting bone formation disorders including ultra-orphan Hypophosphatasia
VR headset with eye-tracking system
Development of a novel nucleic acid therapeutic drug for severe asthma
Mathematics and Technology for visualizing and perceiving hidden things around the world ~Human body, Energy, Building, Planets~
Revolutionizing the Way We Treat Heart Failure ~ Development of novel cell-based therapeutics and a delivery method towards a FIH trial
Human neural stem cell "OligoGenie" as a new therapeutic agent for central nervous system disorders
Cancer gene therapy using a REIC/Dkk‑3 gene with PD-1 inhibitor